Medical sector

Rigor, purity and traceability for critical medical applications

In the medical sector, the company adopts a rigorous and highly controlled approach, considering material purity, traceability and safety of use. Products are developed according to the requirements of Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR) regarding chemical evaluation, in addition to REACH provisions (Regulation (EC) No. 1907/2006) and specific requirements from industry customers.

In the medical sector, the company adopts a rigorous and highly controlled approach, considering material purity, traceability and safety of use. Products are developed according to the requirements of Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR) regarding chemical evaluation, in addition to REACH provisions (Regulation (EC) No. 1907/2006) and specific requirements from industry customers.

Rifra - Medical Markets

Development, compliance and global markets

Internal verification, documentary controls and regulatory updates for safe and technologically advanced products

The development process integrates internal verification, chemical and mechanical compatibility testing, as well as supplier documentary controls. Attention to safety, quality and regulatory compliance is fundamental to ensure reliable and safe products for critical applications. The company also follows regulatory developments and international standards, ensuring that each new product is compliant, technologically advanced and ready for global medical sector markets.